Herpes Simplex Virus Infections Therapeutic Pipeline Projects Vast Growth Ahead

08/gen/2018 20:59:43 P&S research market Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development.


As per the findings of the research, most of the drug candidates are being developed to be administered by oral route. 

Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to, Vector based technology platform, AdenoVerse technology platform, Juvari’s technology platform and Nanostat technology platform.

Download Sample of This Research Report:  https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample


The research found that various companies have collaborated for the development of Herpes simplex virus infections pipeline. In June 2014, PaxVax Inc., entered into a research and development collaboration with the University of California to develop a combination vaccine to prevent genital herpes simplex virus infections.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hsv-infections-therapeutics-pipeline-analysis


Some of the key players developing drugs for the treatment of Herpes virus simplex infections include Maruho Co., Ltd., NanoBio Corporation, Lumavita AG and others.

Herpes Simplex Virus Infections Therapeutics Pipeline Analysis

·          By Phase

·         By Route of Administration

·         By Molecule Type

·         By Company

Scope for Customization

P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:

  • Market Forecast – Market analysis and forecast for the drug candidates in the latest stage of development

·         Company Profiles – Wider company coverage in terms of detailed analysis or additional company profiles



P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl